Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Neuroblastoma 1Multiple Myeloma 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Graft vs Host Disease 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Imatinib Mesylate 10Cytarabine 7Cyclosporine 5Cyclophosphamide 5fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4Dasatinib 4Tacrolimus 3Interferon-alpha 3Idarubicin 3Hydroxyurea 3Busulfan 3tipifarnib 2fludarabine 2belinostat 2Radiotherapy 2Mycophenolic Acid 2Ipilimumab 2Homoharringtonine 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Decitabine 2CTLA-4 Antigen 2Bortezomib 2veliparib 1temsirolimus 1tanespimycin 1sargramostim 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Transplantation × Clear all
NCT00003838 2023-09-21

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
202 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡